Neonatal IV Nutrition Bags Recalled Due to Sterility Assurance Defect
Central Admixture Pharmacy Services is recalling 188 neonatal TPN bags nationwide because sterility assurance cannot be guaranteed. Validation data for decontamination cycles is lacking.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The deficiency in sterility assurance represents a risk-of-harm product where injury has not yet been reported, meeting the rubric criterion for High (score 3).
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling neonatal TPN (Total Parenteral Nutrition) Starter Bags distributed nationwide. The product is a 250mL IV bag containing amino acids (trophamine) 2%, dextrose 10%, calcium, and heparin. Affected lots are 36-254909 (expiration 7/22/2023) and 36-256333 (expiration 7/29/2023).
The manufacturer is recalling the product due to lack of assurance of sterility. Specifically, validation data for the decontamination cycles used in product preparation is lacking. This deficiency prevents confirmation that the product has been properly sterilized.
Neonatal TPN is a critical medication for newborns who cannot receive nutrition by mouth. The sterility of injectable medications is essential to patient safety.
Healthcare facilities and pharmacies that have received the affected lots should verify their inventory using the lot numbers and expiration dates provided. Any remaining recalled product should be handled in accordance with manufacturer and regulatory guidance.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10% with CALCIUM and HEPARIN, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0416-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Parenteral Nutrition
- Hazard
- contamination-risk
- sterility-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: 36-254909
- Exp. 7/22/2023
- 36-256333
- Exp. 7/29/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27